The content on this site is intended for healthcare professionals only
Screening for the fallopian tube as the origin of ovarian cancer
The DESKTOPIII trial in platinum-sensitive ovarian cancer
The patient perspective for HARMONY
HARMONY will have a big impact through inclusion
HARMONY - a bench to bedside process
The importance of the HARMONY project in Europe
Different perspectives shaping the HARMONY project
Returns from data sharing in HARMONY
The Sanger Institute and personalised genomics
Worrying results from genotyping quality assessments
Focus on screening, not biomarkers
Inequalities in immuno-oncology access across Europe
